Monopar Therapeutics

Affinity Asset Advisors, LLC MNPR

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/13/2025

Shares

79,483

Value ($000)

6,491

Weight

0.6%

2025 Q2 - 2025 Q3 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/13/2025	6,491	0.6%	79,483	9/30/2025
2025 Q2	8/13/2025	2,415	0.4%	67,500	6/30/2025